• Citer

Fluoxetine therapy in obese diabetic and glucose intolerant patients

par Kutnowski, Maximilien ;Daubresse, Jean-Claude ;Friedman, Harvey;Kolanowski, Jaroslaw;Krzentowski, Georges;Scheen, André Jacques;Van Gaal, Luc
Référence International journal of obesity, 16, SUPPL. 4, page (S63-S66)
Publication Publié, 1992

Article révisé par les pairs

• Détails
• Contenu

Résumé :

A double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intolerant patients receiving either 60 mg fluoxetine daily (47 patients) or a placebo (50 patients); a similar calorie-restricted diet was prescribed to all patients. Weight loss was significantly higher in the fluoxetine-treated patients, whose diabetic status improved. Drop-out rate was not significantly different for both groups of patients.